Fardella C - Search Results

1

The impact of the micronutrient iodine in health and diseases.

Opazo MC, Coronado-Arrázola I, Vallejos OP, Moreno-Reyes R, Fardella C, Mosso L, Kalergis AM, Bueno SM, Riedel CA. Opazo MC, et al. Among authors: fardella c. Crit Rev Food Sci Nutr. 2022;62(6):1466-1479. doi: 10.1080/10408398.2020.1843398. Epub 2020 Nov 23. Crit Rev Food Sci Nutr. 2022. PMID: 33226264 Review.

2

[Hypertension treatable with glucocorticoids: report of a case].

Montero J, Fardella C, Mosso L. Montero J, et al. Among authors: fardella c. Rev Med Chil. 1997 Nov;125(11):1361-5. Rev Med Chil. 1997. PMID: 9609059 Spanish.

3

[Hypertension and mineralocorticoids. Usefulness of renin and aldosterone measurements].

Fardella CE, Montero J, Mosso L. Fardella CE, et al. Rev Med Chil. 1999 May;127(5):604-10. Rev Med Chil. 1999. PMID: 10451632 Review. Spanish.

4

A(-6)G variant of angiotensinogen gene and aldosterone levels in hypertensives.

Fardella C, Zamorano P, Mosso L, Gómez L, Pinto M, Soto J, Oestreicher E, Cortés P, Claverie X, Montero J. Fardella C, et al. Hypertension. 1999 Oct;34(4 Pt 2):779-81. doi: 10.1161/01.hyp.34.4.779. Hypertension. 1999. PMID: 10523360

5

[High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension].

Mosso L, Fardella C, Montero J, Rojas P, Sánchez O, Rojas V, Rojas A, Huete A, Soto J, Foradori A. Mosso L, et al. Among authors: fardella c. Rev Med Chil. 1999 Jul;127(7):800-6. Rev Med Chil. 1999. PMID: 10668287 Spanish.

6

[Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach].

Cortés P, Fardella C, Oestreicher E, Gac H, Mosso L, Soto J, Foradori A, Claverie X, Ahuad J, Montero J. Cortés P, et al. Among authors: fardella c. Rev Med Chil. 2000 Sep;128(9):955-61. Rev Med Chil. 2000. PMID: 11349499 Spanish.

7

Serum 18-hydroxycortisol in primary aldosteronism, hypertension, and normotensives.

Mosso L, Gómez-Sánchez CE, Foecking MF, Fardella C. Mosso L, et al. Among authors: fardella c. Hypertension. 2001 Sep;38(3 Pt 2):688-91. doi: 10.1161/01.hyp.38.3.688. Hypertension. 2001. PMID: 11566957

8

Primary aldosteronism.

Fardella CE, Mosso L. Fardella CE, et al. Clin Lab. 2002;48(3-4):181-90. Clin Lab. 2002. PMID: 11934220 Review.

9

[11 beta-hydroxysteroid dehydrogenase type 2 activity in Chilean patients with hypertension].

Mosso L, Carvajal C, Campino C, Rojas A, González A, Barraza A, Montero J, Fardella C. Mosso L, et al. Among authors: fardella c. Rev Med Chil. 2002 Nov;130(11):1201-8. Rev Med Chil. 2002. PMID: 12587501 Spanish.

10

Two homozygous mutations in the 11 beta-hydroxysteroid dehydrogenase type 2 gene in a case of apparent mineralocorticoid excess.

Carvajal CA, Gonzalez AA, Romero DG, González A, Mosso LM, Lagos ET, Hevia Mdel P, Rosati MP, Perez-Acle TO, Gomez-Sanchez CE, Montero JA, Fardella CE. Carvajal CA, et al. J Clin Endocrinol Metab. 2003 Jun;88(6):2501-7. doi: 10.1210/jc.2002-021909. J Clin Endocrinol Metab. 2003. PMID: 12788846

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

163 results

Search Page